Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Renaissance London Heathrow Hotel

10 oct 2018 8:00 a.m. - 11 oct 2018 4:30 p.m.

Bath Road, Hounslow, Middlesex, TW6 2AQ, United Kingdom

2018 European Forum for Qualified Person for Pharmacovigilance (QPPV)

Am I impacted by BREXIT ?

Session Chair(s)

Vicki  Edwards, RPh

Vicki Edwards, RPh

Vice President, Pharmacovigilance Excellence and International QPPV

Abbvie, United Kingdom

Brian  Edwards, DrMed

Brian Edwards, DrMed

Vice President

International Society of Pharmacovigilance, United Kingdom

This session will address some of the uncertainty surrounding the QPPV role and Brexit. What are practical implications of Brexit for UK based QPPVs? What is the impact for MAHs if QPPV moves and the team remains UK based? What is the legal situation concerning the definition ‘reside and operate in the EU? Does this mean meeting rules for residency rather than just ‘work out of’? Will there be an impact on the deputy QPPV (or ‘back-up’)? These questions and more we’ll try and answer in what promises to be a lively discussion.

Speaker(s)

Mick  Foy

Mick Foy

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Director of Delivery

Tim  Sarson

Turning Confusing Political Scenarios into Workable Plans

Tim Sarson

KPMG, United Kingdom

Partner, Life Sciences Lead for Brexit

Vicki  Edwards, RPh

Vicki Edwards, RPh

Abbvie, United Kingdom

Vice President, Pharmacovigilance Excellence and International QPPV

Elspeth  McIntosh, MBA, RN

Elspeth McIntosh, MBA, RN

Castle Pharmacovigilance Ltd, United Kingdom

Director

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.